Key Insights

Highlights

Success Rate

75% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

9.1%

1 terminated out of 11 trials

Success Rate

75.0%

-11.5% vs benchmark

Late-Stage Pipeline

18%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

75% success

Data Visualizations

Phase Distribution

11Total
Not Applicable (8)
P 2 (1)
P 3 (1)
P 4 (1)

Trial Status

Recruiting4
Completed3
Unknown3
Terminated1

Trial Success Rate

75.0%

Benchmark: 86.5%

Based on 3 completed trials

Clinical Trials (11)

Research Network

Activity Timeline